secwatch.observer — SEC 8-K summary
======================================

Issuer:     WATERS CORP /DE/ (WAT)
CIK:        0001000697
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001193125-26-042819
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 2.01, 2.03, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Waters completes $4B combination with BD's Biosciences & Diagnostic Solutions; forms four divisions
--------------------------------------------------------------------------------

- Consummated spin-off and merger of BD's Biosciences & Diagnostic Solutions; BD shareholders received ~0.135 Waters shares per BD share, owning 39.2% of combined company.
- SpinCo borrowed $4.0B term loan to fund cash payment to BD; Waters guaranteed the debt.
- Claire M. Fraser, Ph.D. appointed to Waters Board, increasing size to 11.
- New structure: four divisions - Analytical Sciences, Biosciences, Advanced Diagnostics, Materials Sciences.
- Combined entity focused on high-volume testing in regulated applications; expects long-term value creation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000697/000119312526042819/0001193125-26-042819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000697/000119312526042819/d23927d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-042819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer